Investigational New Drug (IND)

See the following -

Soaring Clinical Trials Costs And Effects On Drug Prices

Ryan Haake | PharmaThought | August 5, 2014

The cost to bring a new drug to market has skyrocketed over the past several decades and, in large part, is due to the rising cost of clinical trials. In 2013, Forbes magazine estimated it would cost a company over $350 million for one drug to reach patients...

Read More »

Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis

Press Release | Transparency Life Sciences | September 8, 2014

Transparency Life Sciences, LLC (TLS)...today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).

Read More »